Voclosporin + Placebo Oral Capsule
Phase 3Completed 0 watching 0 views this week๐ Rising
72
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 24
Phase 35
ApprovedIndication / Disease
Lupus Nephritis
Conditions
Lupus Nephritis
Trial Timeline
May 17, 2017 โ Oct 10, 2019
NCT ID
NCT03021499About Voclosporin + Placebo Oral Capsule
Voclosporin + Placebo Oral Capsule is a phase 3 stage product being developed by Aurinia Pharmaceuticals for Lupus Nephritis. The current trial status is completed. This product is registered under clinical trial identifier NCT03021499. Target conditions include Lupus Nephritis.
Hype Score Breakdown
Clinical
27
Activity
18
Company
5
Novelty
9
Community
10
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05288855 | Phase 3 | Terminated |
| NCT03597464 | Phase 3 | Completed |
| NCT03021499 | Phase 3 | Completed |
Competing Products
20 competing products in Lupus Nephritis